Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,476.00    36.00 (2.50%)
Bid:
1,470.00
Ask:
1,478.00
Spread: 8.00 (0.544%)
Market Cap: £505.34m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Significant Contract Win

23 Mar 2017 07:00

RNS Number : 2611A
Craneware plc
23 March 2017
 

Craneware plc

("Craneware", "the Group" or the "Company")

 

Significant Contract Win

 

23 March 2017 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to announce a significant new contract with a large hospital operator in the US.

 

This win, with an existing customer, adds further Value Cycle solutions and related services to a seven year contract originally announced in April 2014. The contract is expected to deliver a further $3.7m of revenue over this new seven year term as the hospital network rolls out these additional solutions across its facilities and $1.5m of additional revenue as the contract for the currently implemented solutions is extended to run co-terminus to this amendment.

 

In accordance with the Company's revenue recognition policy, the majority of the revenue resulting from this contract will be recognised over future periods, adding to the Group's long term visibility of revenue under contract.

 

Keith Neilson, CEO of Craneware plc, commented, "The strategic importance of Craneware's Value Cycle solutions allow us to add new customers and deepen our relationship with our existing customers as both groups address the challenges resulting from the continued evolution to the new value based re-imbursement environment. The extension of the solution set provided to this customer and increasing the duration of the original contract underlines the value our solutions bring to our customers. We have a very positive relationship with our customers, demonstrating sustainable value; we now look forward to this extension of our working relationship with this customer to over a decade."

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Adrian Trimmings

George Sellar

Hilary Buchanan

Robyn McConnachie

Josh Royston

 

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated value cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 250 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTGMGZFMZVGNZZ
Date   Source Headline
2nd Oct 20144:25 pmRNSTotal Voting Rights
23rd Sep 201412:30 pmRNSHolding(s) in Company
23rd Sep 201412:25 pmRNSGrant of Options
16th Sep 20147:00 amRNSFinal Results
1st Sep 20145:20 pmRNSIssue of Consideration Shares
28th Aug 20147:00 amRNSBoard Appointment and Acquisition
17th Jul 201410:46 amRNSTransaction in Own Securities, Total Voting Rights
15th Jul 20147:00 amRNSTrading Update
28th Apr 20147:00 amRNSSignificant Contract Win
16th Apr 20145:00 pmRNSBlocklisting Interim Review
11th Apr 201412:05 pmRNSDirector/PDMR Shareholding
4th Apr 20144:27 pmRNSDirector/PDMR Shareholding
2nd Apr 20147:00 amRNSSignificant Contract Wins
31st Mar 20142:29 pmRNSDividend Currency Election
11th Mar 20147:00 amRNSHalf Yearly Report
16th Jan 20147:00 amRNSTrading Update and Notice of Results
22nd Nov 20134:57 pmRNSHolding(s) in Company
15th Nov 20137:00 amRNSDividend Currency Election
12th Nov 20135:52 pmRNSResult of AGM
12th Nov 20137:00 amRNSAGM Statement and Appointment
18th Oct 20131:57 pmRNSPosting of Annual Report, Notice of AGM
30th Sep 20132:20 pmRNSHolding(s) in Company
12th Sep 20136:25 pmRNSDirector/PDMR Shareholding
11th Sep 20134:40 pmRNSDirector/PDMR Shareholding
11th Sep 20138:50 amRNSGrant of Options
10th Sep 20137:00 amRNSFinal Results
12th Jul 20137:00 amRNSNotice of Results
26th Jun 20137:00 amRNSTrading Update
15th Apr 201311:09 amRNSBlocklisting Interim Review
12th Apr 20135:32 pmRNSTotal Voting Rights
18th Mar 20133:30 pmRNSDividend Currency Election
4th Mar 20134:29 pmRNSTotal Voting Rights
27th Feb 201312:29 pmRNSDirector/PDMR Shareholding
26th Feb 20137:00 amRNSHalf Yearly Report
15th Feb 201312:00 pmRNSHolding(s) in Company
21st Jan 20137:00 amRNSTrading Update
30th Nov 201212:41 pmRNSHolding(s) in Company
9th Nov 20127:00 amRNSDividend Currency Election
8th Nov 201211:45 amRNSResult of AGM
8th Nov 20128:00 amRNSAGM Statement
19th Oct 201212:54 pmRNSBlocklisting Interim Review
10th Oct 20125:32 pmRNSPosting of Annual Report & Notice of AGM
24th Sep 20125:22 pmRNSGrant of Options
19th Sep 20125:53 pmRNSHolding(s) in Company
17th Sep 201211:38 amRNSDirector/PDMR Shareholding
6th Sep 201211:35 amRNSDirector/PDMR Shareholding
4th Sep 20127:00 amRNSFinal Results
29th Aug 20127:00 amRNSesMD Certification
15th Aug 20127:00 amRNSNotice of Results
2nd Aug 20122:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.